The GORE® PROPATEN® Vascular Graft configured for Pediatric Shunt has established a solid reputation for success through:

  • Proven thromboresistant surface: CBAS® Heparin Surface offers lasting thromboresistance. 1,2
  • High performance: Resistance to leakage through the graft wall.
  • Clinical experience: More than 60,000 implants worldwide for more than 15 years.

The GORE® PROPATEN® Vascular Graft configured for Pediatric Shunt is designed to aid in the palliation of cyanotic congenital heart defects in pediatric patients. Our graft delivers proven performance for these challenging patients, including enhanced thromboresistance compared to non-coated grafts via our proprietary CBAS® Heparin Surface3. These shunts all feature a thin-walled configuration, which provides kink resistance, improved handling and better tissue approximation for use in neonates.

  1. Begovac PC, Thomson RC, Fisher JL, Hughson A, Gällhagen A. Improvements in GORE-TEX® Vascular Graft performance by Carmeda® BioActive Surface heparin immobilization. European Journal of Vascular & Endovascular Surgery 2003;25(5):432-437.
  2. Lindholt JS, Gottschalksen B, Johannesen N, et al. The Scandinavian Propaten® trial - 1-year patency of PTFE vascular prostheses with heparin-bonded luminal surfaces compared to ordinary pure PTFE vascular prostheses - a randomised clinical controlled multi-centre trial.  European Journal of Vascular & Endovascular Surgery 2011;41(5):668-673.  OPEN ACCESS https://www.sciencedirect.com/science/article/pii/S1078588411000621
  3. Ashfaq A, Soroya MS, Iyengar A, Federman M, Reemtsen BL. Heparin-coated grafts reduce mortality in pediatric patients receiving systemic-to-pulmonary shunts. Pediatric Cardiology 2018;39(3):473-477.
IFU Consult instructions

Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the market where this product is available. RXOnly

INDICATIONS FOR USE IN EUROPE: GORE® PROPATEN® Vascular Graft is indicated for patients who require replacement or bypass of peripheral vessels due to occlusive or aneurysmal diseases or trauma, or for patients who require arteriovenous hemodialysis access in the upper or lower extremities due to end-stage renal disease (ESRD).

GORE® PROPATEN® Vascular Graft Configured for Pediatric Shunt is indicated for staged palliative repair of cyanotic congenital heart disease (CCHD).

CONTRAINDICATIONS: 
DO NOT use the GORE® PROPATEN® Vascular Graft in patients with known hypersensitivity to heparin, including those patients who have had a previous incidence of Heparin-Induced Thrombocytopenia (HIT) type II.

DO NOT use any of the below configurations of GORE® PROPATEN® Vascular Graft for coronary artery bypass or cerebral reconstruction procedures:

  • GORE® PROPATEN® Vascular Graft Integrated Rings
  • GORE® PROPATEN® Vascular Graft Fixed Ring
  • GORE® PROPATEN® Vascular Graft Removable Ring
  • GORE® PROPATEN® Vascular Graft Removable Ring Axillobifemoral 

DO NOT use GORE® PROPATEN® Vascular Graft as a patch. If cut and used as a patch, GORE® PROPATEN® Vascular Graft may lack adequate transverse strength. 

FOR PATCHING APPLICATIONS: For cardiovascular procedures requiring patch materials, use the appropriate GORE® ACUSEAL Cardiovascular Patch.

Product may not be available in all countries. Please check with your Gore representative for availability.
25CR2010-EN01